К основному контенту

Overweight preschoolers have twice the odds...

 Overweight preschoolers have twice the odds of developing high blood pressure by age 6, putting them at risk of heart attack and stroke later in life.

And those odds begin building as early as age 4, a new study reports.


"The myth that excess weight in children has no consequences hampers the prevention and control of this health problem," said study author Dr. Inaki Galan, from Carlos III Health Institute in Madrid, Spain.

"Parents need to be more physically active with young children and provide a healthy diet," Galan added. "Women should shed extra pounds before becoming pregnant, avoid gaining excess weight during pregnancy, and quit smoking, as these are all established risk factors for childhood obesity."

For the study, Galan and his team looked at the weight and blood pressure of nearly 1,800 4-year-olds. The children were tested again at age 6.

Compared with kids who maintained a healthy weight throughout the study, those who were obese had nearly triple the risk of developing high blood pressure between ages of 4 and 6.

Kids who lost weight did not have the increased risk, the study found.

The report was published June 13 in the European Journal of Preventive Cardiology.

"There is a chain of risk, whereby overweight and obesity lead to high blood pressure, which heightens the chance of cardiovascular disease if allowed to track into adulthood," Galan said in a journal news release. "But the results show that children who return to a normal weight also regain a healthy blood pressure."

Комментарии

  1. Why do opioid overdose deaths spike after cold snaps?

    ОтветитьУдалить
    Ответы
    1. That's the mystery Brown University researchers set out to solve in a study of more than 3,000 opioid-related deaths in Connecticut and Rhode Island between 2014 and 2017.
      The new analysis uncovered a 25% increase in opioid overdose deaths within three to seven days of freezing temperatures, compared to stretches when the temperature averaged 52 degrees Fahrenheit.
      "Regardless of what is causing the correlation between cold weather and fatal overdoses, our findings suggest that agencies and organizations should consider scaling up harm-reduction efforts after a period of cold weather," said study leader Brandon Marshall. He is an associate professor of epidemiology at the Providence, R.I.-based university.
      Opioids -- such as heroin, morphine and oxycodone (OxyContin) -- depress respiration and that can cause a deadly overdose. But, Marshall said in a university news release, "There may be a host of other risk factors that contribute to opioid overdose deaths, which could be avenues for effective interventions."
      Those interventions might include public health messages to remind people to check on neighbors and loved ones who use opioids, and to warn users not to use the drugs when they are alone, Marshall said.
      While the precise reasons for the uptick in overdoses after cold snaps are unclear, there are several ways cold weather may increase the risk, according to the researchers.
      Both opioids and cold weather make breathing more difficult. Some opioids also reduce the temperature where shivering starts, making it harder to regulate your body temperature, the researchers explained.
      Cold weather also changes behavior, they added. People may be more likely to be alone when they use opioids, meaning no one is with them to administer the overdose-reversal drug naloxone (Narcan).
      Cold weather also may affect users' access to opioids. That could increase the risk that they will use drugs containing illicit fentanyl or those that are more potent than they're used to, the study authors suggested.

      Удалить

Отправить комментарий

Популярные сообщения из этого блога

A healthy diet may trigger a better response to a certain kind of melanoma treatment. How?

New research suggests that a diet that's full of fiber appears to lead to more diverse intestinal bacteria (microbiome). In turn, a thriving gut microbiome is linked to a stronger response to an immune therapy for the aggressive skin cancer. "We found that patients eating a high-fiber diet at the start of therapy were about five times more likely to respond to the anti-PD-1 immunotherapy," said study author Christine Spencer. She's a research scientist with the Parker Institute for Cancer Immunotherapy in San Francisco. Anti-PD-1 immunotherapy helps the immune system recognize cancer cells as dangerous cells that need to be destroyed, according to the American Cancer Society (ACS). The cancer drugs Keytruda and Opdivo are examples of this type of immunotherapy. Melanoma is a type of skin cancer. It only accounts for about 1 percent of all skin cancers, but is responsible for most skin cancer deaths, the ACS says. Several recent studies have suggested that a ...

American Heart Association News

On Feb. 1, 1961, twins Debbie and Donna Horst arrived at the White House to fanfare. The 6-year-olds, decked out in fancy dresses and satin sashes, found themselves surrounded by a pressing crowd and a sea of blinding flashbulbs as they made their way to see Jacqueline Kennedy. The girls -- both born with holes in their aortas -- were meeting with the first lady to kick off a national campaign to raise awareness about congenital heart defects. "There were hundreds of reporters because this was Jacqueline Kennedy' first public act as first lady," Debbie said. She recalls being startled when the reporters asked Mrs. Kennedy if they could move in closer. "It was frightening because they all jumped at us at once." The Pennsylvania twins, just a few weeks from turning 7, were among the first "Heart Fund Sweethearts" in the campaign to raise money as well as awareness. The month before, they'd met up with Micki and Patricia Gane, also of Pennsylvania...

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla PRINCETON, N.J., May 17, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it has resubmitted to the U.S. Food and Drug Administration (FDA) the NDA for its lead product candidate, Twirla®, an investigational low-dose combined hormonal contraceptive patch (AG200-15).  Agile resubmitted the NDA in response to a December 2017 Complete Response Letter (CRL) from the FDA, which identified deficiencies relating to (i) quality control adhesion test methods for the Twirla manufacturing process, (ii) observations identified during an inspection of a facility of our third-party manufacturer for the Twirla NDA that must be resolved, and (iii) questions on the in vivo adhesion properties of Twirla and their potential relationship to the SECURE clinical trial results. The resubmitted NDA includes the results from a...